VRTX

Vertex Pharmaceuticals Incorporated

Halal Rating :
Comfortable
Last Price $422.10 Last updated:
Market Cap $127.99b
7D Change 2.11%
1 Year Change -4.09%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NASDAQ
Next Earnings Date Nov. 4, 2024

Vertex Pharmaceuticals Incorporated is a global biotechnology company that develops and commercializes medicines to treat serious diseases. The company focuses primarily on developing innovative therapies for cystic fibrosis (CF) and has expanded its pipeline to include treatments for other serious diseases like sickle cell disease, beta thalassemia, type 1 diabetes, and pain management.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $2.77b $1.66b - $7.5m 0.00% 0.45%
June 30, 2024 $2.65b $6.17b - $9.9m 0.00% 0.16%
March 31, 2024 $2.69b $1.56b - $10.4m 0.00% 0.67%

Company Impact

Help us evaluate Vertex Pharmaceuticals Incorporated's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Recent News & Updates